Literature DB >> 7246817

Physostigmine and its effect on six patients with dementia.

J W Ashford, S Soldinger, J Schaeffer, L Cochran, L F Jarvik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7246817     DOI： 10.1176/ajp.138.6.829

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Effects of physostigmine on stimulus encoding in a memory-scanning task.

Authors:  A Wetherell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Physostigmine for Alzheimer's disease.

Authors:  F Coelho; J Birks
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Should older adults be screened for dementia? It is important to screen for evidence of dementia!

Authors:  J Wesson Ashford; Soo Borson; Ruth O'Hara; Paul Dash; Lori Frank; Philippe Robert; William R Shankle; Mary C Tierney; Henry Brodaty; Frederick A Schmitt; Helena C Kraemer; Herman Buschke; Howard Fillit
Journal:  Alzheimers Dement       Date:  2007-04       Impact factor: 21.566

Review 4.  Diagnosis and treatment of dementia in the aged.

Authors:  G W Small; E H Liston; L F Jarvik
Journal:  West J Med       Date:  1981-12

Review 5.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

6.  Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.

Authors:  P B Clarke; M Reuben; H el-Bizri
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.